The FDA granted New York City-based Bristol-Myers Squibb's biologics license application for Opdivo priority review status.
GI & Endoscopy
The FDA approved four GI-related devices in March 2017.
Matthew Grossman, MD, is a gastroenterologist at Clifton-based Gastroenterology Associates of New Jersey.
A study published in Endoscopy expanded on single-case studies which explored how water exchange increased adenoma detection rate.
A study presented at the European Crohn's and Colitis Organization's 2017 Annual Meeting, Feb. 15 to Feb. 17, in Barcelona, Spain, explored how a value-based care model would affect patient outcomes concerning inflammatory bowel disease, Gastroenterology & Endoscopy News reports.
Advertisement
More than 1,300 people surveyed by Philadelphia-based Health Union said they delayed seeking care and felt negative feelings after receiving an initial irritable bowel syndrome diagnosis.
Barry Perkins, MD, is a gastroenterologist at Oklahoma City-based St. Anthony Hospital.
Paris-based Mauna Kea Technologies' confocal laser endomicroscopy platform Cellvizio matches histologic diagnostic findings in relation to major gastrointestinal diseases.
Greensburg, Pa.-based Allegheny Health Network is planning a 23,000-square-foot multispecialty facility with an endoscopy center.
Researchers presented a study at the American Association for Cancer Research's Annual Meeting, April 3, 2017 in Washington, D.C., that examined the effect pesticide exposure plays in developing cancer, Live Science reports.